tiprankstipranks
pc:biobe

Biobeat Technologies Ltd

Biobeat develops a patch-worn, cuff-less 24-hour ambulatory blood pressure monitoring (ABPM) system and is the first to receive FDA clearance for this technology. The company focuses on expanding clinical utilization and commercial adoption of ABPM to improve diagnosis and management of hypertension by providing continuous, high-quality blood pressure data integrated with electronic medical records.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 30, 2025
Series B
$50.00M

Investors

Investor Name
Funding Round

Related News and Analysis